Review Article
Pretreatment Lymphocyte Monocyte Ratio Predicts Long-Term Outcomes in Patients with Digestive System Tumor: A Meta-Analysis
Table 1
Main characteristics of eligible studies.
| Characteristics | Number of studies | Number of patients |
| All eligible studies | 22 | 12829 | Year of publication | | | 2014 | 3 | 1272 | 2015 | 13 | 2951 | 2016 | 6 | 8606 | Endpoint used | | | OS | 18 | 11610 | CSS | 6 | 1770 | DFS/RFS | 13 | 8338 | Method to get UVA HR | | | Reported | 16 | 10853 | Estimated | 6 | 1976 | Multivariate analysis | | | Performed | 21 | 12527 | Unperformed | 1 | 302 | Anatomic structure | | | Gastrointestinal tract | 17 | 11340 | Nongastrointestinal tract | 5 | 1489 | Tumor site | | | Esophagus | 3 | 892 | Stomach | 3 | 1741 | Colorectal | 11 | 8707 | Liver | 2 | 660 | Pancreas | 3 | 829 | Stage | | | NMS | 11 | 9412 | Mixed | 3 | 1789 | MS | 8 | 1628 | Ethnicity | | | Asian | 16 | 11285 | Non-Asian | 6 | 1544 | Cut-off value | | | <3.0 | 10 | 9272 | ≥3.0 | 12 | 3557 | Treatment | | | With surgery | 18 | 12210 | No surgery | 4 | 619 |
|
|
OS: overall survival; CSS: cancer-specific survival; DFS: disease-free survival; RFS: recurrence-free survival; UVA: univariate analysis; HR: hazard ratio; NMS: nonmetastatic stage; MS: metastatic stage.
|